Treating ADHD with Agomelatine

Journal of Attention Disorders

Volumn 16, Issue 4, 2012, Pages 346-348

  Niederhofer, Helmut ^a  

^a Sächsisches Krankenhaus   (Germany)

Author keywords

ADHD; Agomelatine; Neurobiology; Psychopharmacology

Indexed keywords

ACETAMIDE DERIVATIVE; AGOMELATINE; HYPNOTIC SEDATIVE AGENT;

ADOLESCENT; ADULT; ARTICLE; ATTENTION DEFICIT DISORDER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; MALE; TREATMENT OUTCOME;

ACETAMIDES; ADOLESCENT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; FEMALE; HUMANS; HYPNOTICS AND SEDATIVES; MALE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84859616603     PISSN: 10870547     EISSN: 15571246     Source Type: Journal    
DOI: 10.1177/1087054711417400     Document Type: Article

References (11)

1. American Psychiatric Association. (1987). Diagnostic and statistical manual of mental disorders (3rd ed., revised). Washington, DC: Author.
2. Biederman, J., Newcorn, J., & Sprich, S. (1991). Comorbidity of attention deficit hyperactivity disorder with conduct, depressive, anxiety, and other disorders. American Journal of Psychiatry, 148, 564-577.
3. Faraone, S. V., Biederman, J., Keenan, K., & Tsuang, M. T. (1991). Separation of DSM-III attention deficit disorder and conduct disorder: Evidence from a family-genetic study of American child psychiatric patients. Psychological Medicine, 21, 109-121.
4. Firestone, P. (1982). Factors associated with patients' adherence to stimulant medication. American Journal of Orthopsychiatry, 52, 447-457.
5. Gualtieri, C. T., Golden, R. N., & Fahs, J. J. (1983). New developments in pediatric psychopharmacology. Journal of Developmental and Behavioral Pediatrics, 4, 202-209.
6. Hunt, R. D. (1987). Treatment effects of oral and transdermal clonidine in relation to methylphenidate: An open pilot study in ADD-H. Psychopharmacology Bulletin, 123, 111-114.
7. Hunt, R. D. (1988). Attention deficit disorder: Diagnosis, assessment and treatment. In C. Kestenbaum & D. Williams (Eds.), Handbook of clinical assessment of patients and adolescents: A biopsychosocial approach (Vol. II, pp. 519-561). New York, NY: New York University Press.
8. Hunt, R. D., Minderaa, R. B., & Cohen, D. J. (1985). Clonidine benefits patients with attention deficit disorder and hyperactivity: Report of a double-blind placebo-controlled crossover study. Journal of the American Academy of Child Psychiatry, 24, 617-629.
9. Quintana, H., Butterbaugh, G. J., Purnell, W., & Layman, A. K. (2007). Fluoexitine monotherapy in attention-deficit/hyperactivity disorder and comorbid non-bipolar mood disorders in children and adolescents. Child Psychiatry and Human Development, 37, 241-253.
10. Rapport, M. D., Denney, C., DuPaul, G. J., & Gardner, M. J. (1994). Attention deficit disorder and methylphenidate: Normalization rates, clinical effectiveness, and response prediction in 76 patients. Journal of the American Academy of Child Psychiatry, 33, 882-893.
11. Ward, M. F., Wender, P. H., & Reimherr, F. W. (1993). The Wender Utah Rating Scale: An aid in the retrospective diagnosis of childhood attention deficit hyperactivity disorder. American Journal of Psychiatry, 150, 885-890.